Navigation Links
Fine-tuning treatments for depression
Date:10/18/2009

CHICAGO -- New research clarifies how neurotransmitters like norepinephrine, serotonin, and dopamine, are regulated a finding that may help fine-tune therapies for depression.

Current drugs for depression target the regulatory process for neurotransmitters, and while effective in some cases, do not appear to work in other cases.

Recent findings suggest that synucleins, a family of small proteins in the brain, are key players in the management of neurotransmitters -- specifically, alpha- and gamma-synuclein. Additionally, researchers have found elevated levels of gamma-synuclein in the brains of both depressed animals and humans.

In a study presented at the 39th annual meeting of the Society for Neuroscience, Georgetown University Medical Center researchers observed increased depressive-like behavior in mice where gamma-synuclein acts alone to regulate neurotransmitters, confirming earlier studies by this group.

"These findings show the importance of, and clarify a functional role for, gamma synuclein in depression and may provide new therapeutic targets in treatment of this disease," says Adam Oaks, a student researcher in the Laboratory of Molecular Neurochemistry at GUMC. "Understanding how current therapies work with the synucleins is important because the drugs don't work for all patients, and some are associated with side effects including an increased risk of suicide."


'/>"/>

Contact: Karen Mallet
km463@georgetown.edu
215-514-9751
Georgetown University Medical Center
Source:Eurekalert

Page: 1

Related medicine news :

1. Fine-Tuning Prosthetic Hands to Restore a Sense of Touch
2. Studying cancer in pet dogs to find new treatments for human patients
3. DNA test could be key to targeting treatments for head and neck cancer
4. Chronic pain treatments work better together, says anesthesiologist
5. $16.8 million grant awarded to develop platelet recovery treatments
6. Dr. Marc Katz, Leading Podiatric Surgeon Adds High Powered Color Ultrasound To Cryosurgery Procedures and Treatments
7. New Treatments Hold Hope for Failing Eyes
8. National Autism Center Releases Groundbreaking Report on Autism Treatments
9. Women's Pelvic Organ Prolapse and Incontinence Guide Informs, Outlines Treatments
10. A Dementia That Afflicts Younger Population Has Similarities to Alzheimers, Applicable Treatments
11. Guatemala Treatment Center Becomes First in Latin America to Introduce Fast and Precise RapidArc Radiotherapy Cancer Treatments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2016)... ... May 23, 2016 , ... Edward D. Buckingham, M.D ... America's Best Physicians. The annual roster is put out by the National Consumer Advisory ... commitment to outstanding care are considered for this award. , The National Consumer Advisory ...
(Date:5/23/2016)... ... May 23, 2016 , ... Researchers can find themselves in a state of ... at this technique may yield big benefits. Scientists might be surprised to learn how ... cell culture laboratory—and lessen the risk of contamination when working with eukaryotic cells. , ...
(Date:5/23/2016)... ... 2016 , ... In light of National Heat Awareness Day ... intervening at the first sign of their pet overheating is the key to ... keep the body’s temperature within a safe range. Considered a veterinary emergency, heatstroke ...
(Date:5/23/2016)... ... May 23, 2016 , ... The Society for Women’s Health ... to move on from that role. , “No one in Washington led the way ... said SWHR Founder Florence Haseltine, MD, PhD. “We offer our deep gratitude to Phyllis ...
(Date:5/23/2016)... ... May 23, 2016 , ... Hadley Institute for the Blind ... are blind or visually impaired, announces the election of Julie S. Tye as ... Hadley’s Board of Trustees retained Morris & Berger, a firm specializing in non-profit ...
Breaking Medicine News(10 mins):
(Date:5/23/2016)... JERUSALEM , May 23, 2016 ... DNA for detection of multiple diseases; ,Technology to be ... Yissum Research Development Company of the ... entered into a research agreement with Aurum Ventures MKI, the ... the development of a new diagnostic approach for early ...
(Date:5/22/2016)... , May 23, 2016 ... develop its anti-fibrotic and anti-inflammatory compound DS102 in ... as in non-alcoholic steatohepatitis (NASH) patients. ... significantly sequestered in lung tissue and has bronchodilatory, ... after oral administration. The Company will publish further ...
(Date:5/20/2016)... 2016 ReportsnReports.com adds "Plaque ... market research report with comprehensive information on the ... with comparative analysis at various stages, therapeutics assessment ... of administration (RoA) and molecule type, along with ... It also reviews key players involved in the ...
Breaking Medicine Technology: